Phibro Animal Health Corporation (PAHC)
USD 18.14
(-5.47%)
USD 18.14
(-5.47%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 982.18 Million USD | 1.11% |
| 2023 | 971.39 Million USD | 4.26% |
| 2022 | 931.69 Million USD | 10.74% |
| 2021 | 841.32 Million USD | 7.3% |
| 2020 | 784.1 Million USD | 7.9% |
| 2019 | 726.67 Million USD | 8.19% |
| 2018 | 671.67 Million USD | 7.74% |
| 2017 | 623.39 Million USD | 2.13% |
| 2016 | 610.37 Million USD | 23.73% |
| 2015 | 493.31 Million USD | 4.45% |
| 2014 | 472.32 Million USD | -0.38% |
| 2013 | 474.14 Million USD | 7.54% |
| 2012 | 440.9 Million USD | 0.0% |
| 2007 | 271.9 Million USD | 9.5% |
| 2006 | 248.3 Million USD | -1.9% |
| 2005 | 253.1 Million USD | 4.85% |
| 2004 | 241.4 Million USD | -11.99% |
| 2003 | 274.3 Million USD | -7.46% |
| 2002 | 296.4 Million USD | -10.18% |
| 2001 | 330 Million USD | 27.66% |
| 2000 | 258.5 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 972.7 Million USD | 0.85% |
| 2024 FY | 982.18 Million USD | 1.11% |
| 2024 Q3 | 979.03 Million USD | 0.65% |
| 2024 Q4 | 982.18 Million USD | 0.32% |
| 2024 Q1 | 964.52 Million USD | -0.71% |
| 2023 Q3 | 965.43 Million USD | 0.37% |
| 2023 Q1 | 948.37 Million USD | 1.79% |
| 2023 FY | 971.39 Million USD | 4.26% |
| 2023 Q4 | 971.39 Million USD | 0.62% |
| 2023 Q2 | 961.83 Million USD | 1.42% |
| 2022 FY | 931.69 Million USD | 10.74% |
| 2022 Q3 | 916.18 Million USD | 7.92% |
| 2022 Q4 | 931.69 Million USD | 1.69% |
| 2022 Q1 | 836.04 Million USD | -0.63% |
| 2022 Q2 | 848.95 Million USD | 1.54% |
| 2021 Q3 | 805.01 Million USD | 0.17% |
| 2021 Q4 | 841.32 Million USD | 4.51% |
| 2021 Q2 | 803.65 Million USD | 1.79% |
| 2021 FY | 841.32 Million USD | 7.3% |
| 2021 Q1 | 789.55 Million USD | 0.7% |
| 2020 FY | 784.1 Million USD | 7.9% |
| 2020 Q1 | 795.23 Million USD | 9.44% |
| 2020 Q3 | 776.05 Million USD | -1.56% |
| 2020 Q4 | 784.1 Million USD | 1.04% |
| 2020 Q2 | 788.31 Million USD | -0.87% |
| 2019 Q2 | 697.29 Million USD | 2.77% |
| 2019 Q3 | 706.42 Million USD | 1.31% |
| 2019 Q4 | 726.67 Million USD | 2.87% |
| 2019 FY | 726.67 Million USD | 8.19% |
| 2019 Q1 | 678.47 Million USD | 1.01% |
| 2018 Q1 | 671.11 Million USD | 7.65% |
| 2018 Q3 | 670.84 Million USD | 1.16% |
| 2018 Q4 | 671.67 Million USD | 0.12% |
| 2018 FY | 671.67 Million USD | 7.74% |
| 2018 Q2 | 663.13 Million USD | -1.19% |
| 2017 Q3 | 602.27 Million USD | 1.69% |
| 2017 Q4 | 623.39 Million USD | 3.51% |
| 2017 FY | 623.39 Million USD | 2.13% |
| 2017 Q1 | 598.08 Million USD | -2.01% |
| 2017 Q2 | 592.28 Million USD | -0.97% |
| 2016 Q4 | 610.37 Million USD | 3.47% |
| 2016 Q3 | 589.88 Million USD | 13.11% |
| 2016 Q1 | 493.47 Million USD | 0.03% |
| 2016 Q2 | 521.49 Million USD | 5.68% |
| 2016 FY | 610.37 Million USD | 23.73% |
| 2015 Q3 | 472.33 Million USD | 1.0% |
| 2015 FY | 493.31 Million USD | 4.45% |
| 2015 Q4 | 493.31 Million USD | 4.44% |
| 2015 Q2 | 467.67 Million USD | -0.67% |
| 2015 Q1 | 470.82 Million USD | -0.32% |
| 2014 Q4 | 472.32 Million USD | -0.2% |
| 2014 Q1 | 483.2 Million USD | 1.91% |
| 2014 FY | 472.32 Million USD | -0.38% |
| 2014 Q2 | 480.82 Million USD | -0.49% |
| 2014 Q3 | 473.27 Million USD | -1.57% |
| 2013 Q4 | 474.14 Million USD | 0.0% |
| 2013 FY | 474.14 Million USD | 7.54% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | 440.9 Million USD | 0.0% |
| 2007 FY | 271.9 Million USD | 9.5% |
| 2006 Q3 | 243.8 Million USD | 1.08% |
| 2006 FY | 248.3 Million USD | -1.9% |
| 2006 Q1 | 248.9 Million USD | -1.66% |
| 2006 Q2 | 241.2 Million USD | -3.09% |
| 2005 Q2 | 265.1 Million USD | 8.83% |
| 2005 Q1 | 243.6 Million USD | 0.91% |
| 2005 FY | 253.1 Million USD | 4.85% |
| 2005 Q4 | 253.1 Million USD | -1.21% |
| 2005 Q3 | 256.2 Million USD | -3.36% |
| 2004 Q1 | 276.2 Million USD | 0.69% |
| 2004 Q4 | 241.4 Million USD | -4.55% |
| 2004 Q3 | 252.9 Million USD | -0.78% |
| 2004 FY | 241.4 Million USD | -11.99% |
| 2004 Q2 | 254.9 Million USD | -7.71% |
| 2003 Q2 | 286.1 Million USD | 0.28% |
| 2003 Q1 | 285.3 Million USD | 0.0% |
| 2003 FY | 274.3 Million USD | -7.46% |
| 2003 Q4 | 274.3 Million USD | -2.9% |
| 2003 Q3 | 282.5 Million USD | -1.26% |
| 2002 FY | 296.4 Million USD | -10.18% |
| 2001 FY | 330 Million USD | 27.66% |
| 2000 FY | 258.5 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cosmos Health Inc. | 66.29 Million USD | -1381.523% |
| Safety Shot Inc | 12.7 Million USD | -7628.146% |
| Bright Green Corporation | 17.4 Million USD | -5543.747% |
| Embecta Corp. | 1.21 Billion USD | 19.122% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | -8.598% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | -1610.586% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 14.093% |
| Dynavax Technologies Corporation | 997.09 Million USD | 1.496% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | -377.261% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | -34.861% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 37.615% |
| PainReform Ltd. | 9.93 Million USD | -9791.078% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -3491.565% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -3491.565% |
| SCYNEXIS, Inc. | 128.41 Million USD | -664.869% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -4146.904% |
| Journey Medical Corporation | 76.84 Million USD | -1178.07% |
| Alpha Teknova, Inc. | 128.58 Million USD | -663.828% |
| Procaps Group, S.A. | 460.18 Million USD | -113.431% |
| Theratechnologies Inc. | 77.76 Million USD | -1162.951% |
| Harrow Health, Inc. | 311.75 Million USD | -215.05% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -6494.937% |
| Biofrontera Inc. | 27.93 Million USD | -3416.34% |
| DURECT Corporation | 45.18 Million USD | -2073.502% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 30.291% |
| Cronos Group Inc. | 1.13 Billion USD | 13.407% |
| OptiNose, Inc. | 107.72 Million USD | -811.717% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | -108.499% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -1655.499% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -4161.631% |
| Organogenesis Holdings Inc. | 460.02 Million USD | -113.507% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -8141.059% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | -1101.065% |
| Radius Health, Inc. | 1.71 Billion USD | 42.761% |
| Universe Pharmaceuticals INC | 53.28 Million USD | -1743.195% |
| ProPhase Labs, Inc. | 91.92 Million USD | -968.439% |
| Procaps Group S.A. | 460.18 Million USD | -113.431% |
| Alvotech | 950.09 Million USD | -3.378% |
| TherapeuticsMD, Inc. | 43.3 Million USD | -2167.852% |
| Viatris Inc. | 47.68 Billion USD | 97.94% |
| Rockwell Medical, Inc. | 52.17 Million USD | -1782.552% |
| Aytu BioPharma, Inc. | 118.09 Million USD | -731.69% |
| SIGA Technologies, Inc. | 254.83 Million USD | -285.418% |
| Tilray Brands, Inc. | 4.33 Billion USD | 77.344% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | -258.852% |
| Shineco, Inc. | 84.17 Million USD | -1066.775% |
| PetIQ, Inc. | 868.22 Million USD | -13.125% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -11539.718% |
| Incannex Healthcare Limited | 17.04 Million USD | -5661.624% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 69.792% |
| Alimera Sciences, Inc. | 153.52 Million USD | -539.759% |
| Silver Spike Investment Corp. | 88.57 Million USD | -1008.857% |
| Assertio Holdings, Inc. | 286.41 Million USD | -242.919% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -16402.479% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | -2806.231% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | -3043.693% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -7314.087% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | -276.134% |
| Hempacco Co., Inc. | 18.04 Million USD | -5343.55% |
| Talphera, Inc. | 20.39 Million USD | -4715.808% |
| Alvotech | 950.09 Million USD | -3.378% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | -141.822% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 40.515% |
| Currenc Group, Inc. | 141.49 Million USD | -594.17% |
| Kamada Ltd. | 351.96 Million USD | -179.054% |
| Indivior PLC | 1.95 Billion USD | 49.664% |
| Evoke Pharma, Inc. | 7.06 Million USD | -13795.135% |
| Flora Growth Corp. | 23.62 Million USD | -4057.217% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -7314.087% |
| Evolus, Inc. | 188.99 Million USD | -419.68% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 23.253% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 35.08% |
| Akanda Corp. | 8.83 Million USD | -11010.688% |